RxDoctor Payments Data

Steven Abram, MD

Neurological Surgery · Nashville, TNNPI 1285604454

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (49.5%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. Monteris Medical Corporation accounts for 82.9% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $4,366 and has fallen 76.1% since, to $1,043 in 2025.

$12,920in general payments, 2019–2025

Across 57 payments — averaging $226.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Monteris Medical Corporation$11K
  • Brainlab, Inc.$488
  • Abbott$473
  • Augmedics Inc.$310
  • Medtronic$280
  • Merck$125
  • plus $527 from 7 others
$201,890in research payments, 2019–2025

Across 63 payments — averaging $3204.60 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Monteris Medical Corporation$202K

What the payments were for

  • Consulting fees$6,40050%
  • Speaking & faculty fees$2,50019%
  • Travel & lodging$8386%
  • Food & beverage$3,18225%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Monteris Medical Corporation25$10,717
Brainlab, Inc.5$488
Abbott13$473
Augmedics Inc.1$310
Medtronic(2 entities)5$280
Merck1$125
Spine Wave, Inc.1$120
Novocure Inc.1$118
Synaptive Medical Inc.1$107
Johnson & Johnson1$104
Stryker1$45
Zimmer Biomet1$20
Integra Lifesciences Corporation1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,920 in reported general payments places this provider in the 70th percentile of 156 neurological surgery providers in Tennessee.

See all neurological surgery providers in Tennessee

Medicare billing

Part B allowed, 2024
$296,028
Medicare patients
341
Services billed
1,095

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tizanidine Hcl195$998
Meloxicam241$523
Gabapentin35$424
Oxcarbazepine12$398
Methylprednisolone26$205
Methocarbamol12$142
Celecoxib16$130
Cyclobenzaprine Hcl29$105
Tramadol Hcl33$97
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen11$44
Alprazolam11$5

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →